YGR025W Antibody

What is YGR025W and why is it relevant to yeast genetics research?

YGR025W encodes a hypothetical protein in Saccharomyces cerevisiae S288C, located on chromosome VII . The gene was initially identified during the comprehensive sequencing of the S. cerevisiae genome, as documented in landmark studies by Tettelin et al. (1997) and Goffeau et al. (1996) . As a hypothetical protein, YGR025W represents one of the uncharacterized open reading frames that comprise a significant portion of the yeast genome despite extensive study. This makes it particularly valuable for research into novel protein functions and evolutionary biology.

The protein has been assigned UniProt accession number P53216 and is available as a research target through commercially available antibodies . The nucleotide sequence length of the YGR025W ORF is 303bp, encoding a relatively small protein product . The continued study of hypothetical proteins like YGR025W is crucial for completing our understanding of yeast cellular function and identifying potentially conserved mechanisms across eukaryotes.

What expression systems are available for studying YGR025W?

Researchers have multiple options for studying YGR025W in experimental systems. The gene's cDNA ORF clone is available in expression vectors, most notably the pcDNA3.1-C-(k)DYK system or customized vectors for transfection-ready applications . These expression systems allow for heterologous expression of the YGR025W protein in various cell types beyond yeast.

For native expression studies, researchers can work directly with the S. cerevisiae S288C strain, which serves as the reference genome for most yeast genetic studies. When designing expression experiments, it's important to consider:

• Promoter selection appropriate for your experimental conditions

• Inclusion of epitope tags that won't interfere with protein function

• Control constructs expressing known yeast proteins

• Validation of expression through western blotting using anti-YGR025W antibodies

The relatively small size of YGR025W (303bp) makes it particularly amenable to PCR-based cloning strategies and site-directed mutagenesis approaches for functional characterization .

How does YGR025W relate to chromatin structure research?

While YGR025W itself is not directly identified in the search results as a major player in chromatin structure, it exists within the research context of important chromatin remodeling factors in yeast. The search results reference studies examining proteins such as Arp6, Swr1, and Htz1 (the yeast homolog of histone variant H2A.Z), which are critical components of chromatin remodeling complexes .

Chromatin immunoprecipitation (ChIP) techniques using antibodies against these factors have been instrumental in understanding how chromatin structure affects gene expression. Researchers investigating YGR025W may benefit from examining its genomic context in relation to binding sites for these chromatin remodeling factors. The ChIP methodology described in the supporting information can be adapted for YGR025W studies:

$\text{Enrichment} = \frac{\text{\% Input DNA recovered by ChIP}}{\text{Control region recovery}}$

In particular, research suggests connections between hypothetical proteins and nuclear organization that might be relevant to YGR025W function. The search results indicate chromatin immunoprecipitation protocols that could be adapted to study YGR025W's potential role in nuclear organization or its regulation by chromatin structure .

What experimental approaches are most effective for characterizing hypothetical proteins like YGR025W?

Characterizing hypothetical proteins like YGR025W requires a multi-faceted approach that combines computational prediction with experimental validation. Based on research methodologies referenced in the search results, the following experimental pipeline is recommended:

• Computational Analysis:

  • Sequence homology searches to identify potential functional domains

  • Structural prediction using modern AI-based tools

  • Protein interaction network analysis

• Expression Analysis:

  • Real-time quantitative RT-PCR under various growth conditions (as performed for other yeast genes like RDS1 and UBX3)

  • Comparison between wild-type and mutant strains (arp6Δ, swr1Δ, etc.)

  • Correlation analysis with co-regulated genes

• Localization Studies:

  • Fluorescent protein tagging to determine subcellular localization

  • ChIP analysis to determine potential chromatin association

  • Co-localization studies with known nuclear structures

• Functional Analysis:

  • Deletion mutant phenotyping (growth rates, stress responses)

  • Synthetic genetic interaction screens

  • Targeted biochemical assays based on predicted function

The rigor of this approach is supported by similar methodologies used for other yeast genes in the referenced literature, where researchers quantified gene expression relative to ACT1 as a control and performed statistical analysis to determine significant changes .

How can researchers optimize ChIP protocols specifically for YGR025W antibody applications?

Optimizing ChIP protocols for YGR025W antibody requires careful consideration of several parameters based on successful approaches with other yeast proteins. The supporting information provides valuable insights into ChIP methodology that can be adapted for YGR025W studies .

Key Optimization Steps:

• Crosslinking Optimization:

  • Test multiple formaldehyde concentrations (1-3%)

  • Evaluate various crosslinking times (10-30 minutes)

  • Consider dual crosslinking with additional agents for improved protein-DNA capture

• Sonication Parameters:

  • Optimize sonication conditions to achieve 200-500bp DNA fragments

  • Verify fragment size by agarose gel electrophoresis

  • Establish a consistent protocol with appropriate controls

• Antibody Validation:

  • Perform initial immunoprecipitation tests with varying antibody concentrations

  • Include no-antibody and IgG controls

  • Validate antibody specificity through western blots against wild-type and knockout strains

• Quantification Methods:

  • Use real-time quantitative PCR as demonstrated in the supporting materials

  • Calculate enrichment as percentage of input DNA

  • Perform at least three independent experiments for statistical significance

A sample ChIP workflow based on the methodology in the supporting information would include:

\begin{table}
\begin{tabular}{|l|l|}
\hline
\textbf{ChIP Step} & \textbf{Specific Protocol for YGR025W} \
\hline
Cell Growth & S. cerevisiae culture to mid-log phase (OD₆₀₀ ~0.8) \
\hline
Crosslinking & 1% formaldehyde, 20 minutes, room temperature \
\hline
Cell Lysis & Glass bead disruption in lysis buffer with protease inhibitors \
\hline
Chromatin Preparation & Sonication to 300bp average fragment size \
\hline
Immunoprecipitation & Anti-YGR025W antibody (CSB-PA347392XA01SVG), overnight at 4°C \
\hline
Washing & Sequential washes with increasing stringency buffers \
\hline
Elution & Two-step elution at 65°C \
\hline
Reverse Crosslinking & 65°C for 6 hours \
\hline
DNA Purification & Phenol-chloroform extraction and ethanol precipitation \
\hline
Quantification & Real-time qPCR with gene-specific primers \
\hline
\end{tabular}
\end{table}

This approach mirrors successful ChIP experiments performed for chromatin-associated factors like Htz1, which showed measurable enrichment at specific genomic loci .

What strategies can overcome challenges in detecting low-abundance proteins like YGR025W?

Detecting low-abundance hypothetical proteins like YGR025W presents significant challenges that require specialized approaches. Based on techniques referenced in the search results and standard research practices, the following strategies can enhance detection sensitivity:

• Enrichment Strategies:

  • Use of epitope tags (FLAG, HA, etc.) for enhanced antibody recognition

  • Protein concentration through immunoprecipitation prior to detection

  • Expression enhancement through stronger promoters when appropriate

• Signal Amplification Techniques:

  • Enhanced chemiluminescence (ECL) with extended exposure times

  • Tyramide signal amplification for immunofluorescence applications

  • Quantum dot-conjugated secondary antibodies for improved signal stability

• Optimized Western Blot Protocol:

  • Extended primary antibody incubation (overnight at 4°C)

  • Optimized blocking agents to reduce background

  • Semi-dry transfer techniques for efficient protein transfer

• Alternative Detection Methods:

  • Proximity ligation assay (PLA) for detecting protein-protein interactions

  • Mass spectrometry-based targeted proteomics (SRM/MRM)

  • Fluorescence correlation spectroscopy for single-molecule detection

The search results indicate that FLAG-tagged proteins were successfully used for ChIP applications in similar research contexts , suggesting that epitope tagging is a viable approach for enhancing YGR025W detection while maintaining protein functionality.

What controls are essential when using YGR025W antibody for immunoprecipitation experiments?

When conducting immunoprecipitation experiments with YGR025W antibody, implementing proper controls is critical for ensuring experimental validity and interpretable results. Based on rigorous methodologies applied to similar yeast protein studies, the following controls should be incorporated:

• Negative Controls:

  • No-antibody control (beads only) to assess non-specific binding

  • Isotype-matched IgG control to establish background signal

  • Immunoprecipitation using YGR025W deletion strain extract (ygr025wΔ) to confirm antibody specificity

• Positive Controls:

  • Immunoprecipitation of well-characterized yeast proteins of similar abundance

  • Input sample (pre-immunoprecipitation) to confirm target protein presence

  • Spike-in of recombinant YGR025W in negative samples when available

• Validation Controls:

  • Reciprocal immunoprecipitation with interacting partners

  • Competition assays with blocking peptides

  • Multiple antibody sources or epitopes when available

• Technical Controls:

  • Multiple biological replicates (minimum three independent experiments)

  • Standardized protein quantification methods

  • Consistent buffer composition across experimental conditions

Research with other yeast proteins demonstrates the importance of these controls. For example, studies with Arp6 and Swr1 included appropriate negative controls and multiple biological replicates to establish statistical significance . Similar rigor should be applied to YGR025W research.

How can researchers effectively validate YGR025W antibody specificity?

Validating antibody specificity is crucial for reliable research outcomes, particularly for hypothetical proteins like YGR025W where functional data is limited. Based on established validation techniques, researchers should implement a multi-dimensional validation strategy:

• Genetic Validation:

  • Western blot comparison between wild-type and YGR025W deletion strains

  • Analysis of size-shifted tagged versions of YGR025W

  • Conditional expression systems with inducible promoters

• Biochemical Validation:

  • Peptide competition assays using the immunizing peptide

  • Pre-adsorption tests to confirm epitope specificity

  • Mass spectrometry identification of immunoprecipitated proteins

• Cross-reactivity Assessment:

  • Western blot screening against phylogenetically related proteins

  • Testing in multiple yeast strains and related species

  • Evaluation against samples with varying expression levels

• Application-specific Validation:

  • For ChIP: qPCR of regions known to be negative for YGR025W binding

  • For immunofluorescence: comparison with GFP-tagged protein localization

  • For Western blot: multiple antibody dilutions to establish detection limits

These validation approaches align with the rigorous methods applied to chromatin-associated proteins in the supporting information, where specificity was confirmed through multiple experimental approaches .

What are the recommended storage and handling protocols for maintaining YGR025W antibody efficacy?

Proper storage and handling of YGR025W antibody is essential for maintaining its activity and ensuring reproducible experimental results. Based on standard practices for research antibodies and information from suppliers, the following protocols are recommended:

• Storage Conditions:

  • Primary storage: -20°C to -80°C for long-term stability

  • Working aliquots: 4°C for up to one month

  • Avoid repeated freeze-thaw cycles (create single-use aliquots)

• Buffer Considerations:

  • Standard buffer: PBS with 0.02% sodium azide as preservative

  • For enhanced stability: Addition of 50% glycerol for -20°C storage

  • Protein stabilizers: 1% BSA or 5% glycerol may improve shelf-life

• Handling Practices:

  • Allow antibody to equilibrate to room temperature before opening

  • Centrifuge briefly before opening to collect solution at bottom

  • Use sterile technique when accessing antibody solution

• Quality Control:

  • Maintain antibody activity log with dates and experiment outcomes

  • Periodically test against positive control samples

  • Document lot numbers and correlate with experimental results

The Cusabio YGR025W antibody (CSB-PA347392XA01SVG) is supplied in both 2ml and 0.1ml sizes, allowing researchers flexibility in selecting appropriate volumes to minimize freeze-thaw cycles .

How can YGR025W antibody be integrated into multi-omics research approaches?

Integrating YGR025W antibody into multi-omics research requires careful experimental design to generate complementary datasets that provide comprehensive insights into this hypothetical protein's function. Based on current research approaches, the following integration strategies are recommended:

• Genomics Integration:

  • ChIP-seq to identify genomic binding sites or associations

  • Integration with existing chromatin structure data (like Arp6/Swr1 binding)

  • Correlation with genetic interaction networks

• Transcriptomics Correlation:

  • RNA-seq under conditions where YGR025W is expressed/active

  • Comparison of expression profiles between wild-type and YGR025W mutants

  • Integration with existing microarray data from related studies

• Proteomics Applications:

  • IP-MS (immunoprecipitation followed by mass spectrometry) to identify interacting partners

  • RIME (Rapid Immunoprecipitation Mass spectrometry of Endogenous proteins)

  • Protein correlation profiling across cellular fractions

• Data Integration Framework:

  • Computational tools to correlate ChIP-seq, RNA-seq, and proteomics data

  • Network analysis to position YGR025W in cellular pathways

  • Machine learning approaches to predict function from integrated datasets

The microarray analysis methods referenced in the supporting information for analyzing arp6Δ and swr1Δ cells provide a template for generating comparable transcriptomic data that could be integrated with YGR025W studies .

What statistical approaches should be applied when analyzing YGR025W antibody experimental data?

Rigorous statistical analysis is essential for interpreting experimental data generated using YGR025W antibody. Based on methodologies applied in similar research contexts, the following statistical approaches are recommended:

• For ChIP Experiments:

  • Calculate percent input for quantification (as shown in the supporting information)

  • Apply Student's t-test for pairwise comparisons between conditions

  • Use ANOVA for multi-condition experiments followed by appropriate post-hoc tests

  • Establish significance threshold (typically p<0.05) as used in referenced research

• For Expression Analysis:

  • Normalize to housekeeping genes (ACT1 as used in referenced studies)

  • Calculate fold-change relative to control conditions

  • Apply appropriate statistical tests based on data distribution

  • Consider multiple testing correction for genome-wide analyses

• For Protein Interaction Studies:

  • Calculate enrichment ratios relative to control IPs

  • Apply statistical filters to remove non-specific interactors

  • Consider SAINT or similar computational methods for scoring interactions

  • Implement appropriate normalization for label-free quantification

• Reporting Standards:

  • Include biological replicates (n≥3) as done in the referenced studies

  • Report both mean and standard deviation for all measurements

  • Provide raw data access when possible

  • Clearly state statistical tests and thresholds used

The supporting information demonstrates appropriate statistical rigor by indicating "data points represent the mean ± SD for at least three independent experiments" and establishing clear significance thresholds (p<0.05), which should serve as a minimum standard for YGR025W research .

What are the emerging applications for YGR025W antibody in yeast systems biology?

YGR025W antibody represents a valuable tool for expanding our understanding of yeast systems biology, with several emerging applications that leverage recent technological advances. While YGR025W remains categorized as a hypothetical protein, the antibody enables researchers to investigate its role within the broader context of yeast cellular function and regulation.

Potential emerging applications include integration with spatial transcriptomics to understand the relationship between YGR025W localization and gene expression patterns across different cellular compartments. Additionally, the antibody may prove valuable in chromatin conformation capture techniques (Hi-C, Micro-C) to investigate potential roles in three-dimensional genome organization, particularly given the connections between other yeast proteins and nuclear organization referenced in the supporting information .

Another promising direction involves using the antibody in combination with CRISPR-based approaches for real-time tracking of YGR025W in living cells, potentially revealing dynamic behaviors that static approaches might miss. The integration of these methodologies, combined with computational modeling, presents a powerful approach to understanding the functional significance of this hypothetical protein in the broader context of yeast systems biology.

What are the key limitations researchers should consider when interpreting YGR025W antibody data?

The antibody itself presents technical limitations that must be acknowledged. Like all antibodies, it may have some level of non-specific binding or cross-reactivity with structurally similar proteins, particularly in complex biological samples. Additionally, epitope accessibility may vary depending on protein interactions, post-translational modifications, or conformational states, potentially leading to incomplete detection in certain experimental contexts.